Cytoskeletal Protein Variants Driving Atrial Fibrillation: Potential Mechanisms of Action
The most common clinical tachyarrhythmia, atrial fibrillation (AF), is present in 1–2% of the population. Although common risk factors, including hypertension, diabetes, and obesity, frequently underlie AF onset, it has been recognized that in 15% of the AF population, AF is familial. In these famil...
Main Authors: | Stan W. van Wijk, Wei Su, Leonoor F. J. M. Wijdeveld, Kennedy S. Ramos, Bianca J. J. M. Brundel |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-01-01
|
Series: | Cells |
Subjects: | |
Online Access: | https://www.mdpi.com/2073-4409/11/3/416 |
Similar Items
-
The Role of Mitochondrial Dysfunction in Atrial Fibrillation: Translation to Druggable Target and Biomarker Discovery
by: Lisa Pool, et al.
Published: (2021-08-01) -
Cardioprotective Role of Heat Shock Proteins in Atrial Fibrillation: From Mechanism of Action to Therapeutic and Diagnostic Target
by: Stan W. van Wijk, et al.
Published: (2021-01-01) -
The Role of Immune Cells Driving Electropathology and Atrial Fibrillation
by: Mingxin Huang, et al.
Published: (2024-02-01) -
Prevention of Atrial Fibrillation: Putting Proteostasis Derailment Back on Track
by: Preetam Kishore, et al.
Published: (2023-06-01) -
Dissecting the Molecular Mechanisms Driving Electropathology in Atrial Fibrillation: Deployment of RNA Sequencing and Transcriptomic Analyses
by: Fabries G. Huiskes, et al.
Published: (2023-09-01)